CanBioPharma provides:
- Strategic management of nonclinical safety programs to support clinical development of drugs and biologics (human and veterinary) from discovery through safety assessment and registration.
- Issue resolution and expert opinion assessment of the safety and risk-benefit of therapeutic agents and chemicals.
- Evaluation of all aspects of toxicology studies with particular expertise in clinical pathology result interpretation, bone marrow, and histopathology evaluations.
CanBioPharma professionals each have:
- Extensive (20+ years) industrial, contract research laboratory, and governmental experience.
- Board-certification in veterinary clinical or anatomic pathology (DACVP) or in toxicology (DABT).
|
|
